Gemtuzumab ozogamicin for relapsed or primary refractory acute myeloid leukemia in children-the Polish Pediatric Leukemia and Lymphoma Study Group experience.
Pawinska-Wasikowska K, Czogala M, Skoczen S, Surman M, Rygielska M, Ksiazek T, Pac A, Wieczorek A, Skalska-Sadowska J, Samborska M, Wachowiak J, Chaber R, Tomaszewska R, Szczepanski T, Zielezinska K, Urasinski T, Moj-Hackemer M, Kalwak K, Kozlowska M, Irga-Jaworska N, Balwierz W, Bukowska-Strakova K.
Pawinska-Wasikowska K, et al. Among authors: pac a.
Front Immunol. 2023 Dec 22;14:1268993. doi: 10.3389/fimmu.2023.1268993. eCollection 2023.
Front Immunol. 2023.
PMID: 38187390
Free PMC article.